Aramark
NYSEARMK heads into its May 5 earnings release with analysts firmly in the bulls' corner — but the stock's options market tells a quieter story than the Wall Street consensus suggests. The analyst backdrop is unusually constructive. Every recent rating action has been a target raise. UBS lifted its target to $48 in early April. Oppenheimer moved to $50 in late March. Truist and…
Snapshot as of 8 May 2026
ARMK heads into its May 5 earnings release with analysts firmly in the bulls' corner — but the stock's options market tells a quieter story than the Wall Street consensus suggests. The analyst backdrop is unusually…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ARMK — free to start on ORTEX.
Sign up for free →Open ARMK on ORTEX